Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial

Heterogeneous dose escalation did not increase early toxicity despite delivery of 88 Gy mean dose to the primary tumor, demonstrating this as an attractive strategy for LA-NSCLC radiotherapy dose escalation.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-04-18
DOI
https://doi.org/10.1200/jco-24-01386
Citations
5
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
7.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial

Tine Schytte, Marianne Marquard Knap, Ditte Sloth Møller, Svetlana Borissova et al.
5 citations
Journal of Clinical Oncology
Lung Cancer Diagnosis and Treatment
7.59
article

Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial

Tine Schytte, Marianne Marquard Knap, Ditte Sloth Møller, Svetlana Borissova, Charlotte Kristiansen, Erlend Peter Skaug Sande, Christina Maria Lutz, Morten Nielsen, Tarje Onsøien Halvorsen, Lotte Rogg, Rune Slot Thing, Olfred Hansen, Gitte Fredberg Persson, Carsten Brink, Azza A. Khalil, Vilde Drageset Haakensen, C. Peucelle, Mette Poehl, Lone Hoffmann, Ane Lindegaard Appelt, Mikkel Drøgemüller Lund, Wiviann Ottosson, Tine Bjørn Nielsen, Torben Stiig Hansen, Lotte Holm Land, Nina Jackson Levin, F. Sundby, H Schmidt
article en
5 citations

Abstract

Heterogeneous dose escalation did not increase early toxicity despite delivery of 88 Gy mean dose to the primary tumor, demonstrating this as an attractive strategy for LA-NSCLC radiotherapy dose escalation.

Journal of Clinical OncologyVol. 43(17)
Oslo University Hospital (NO), University of Leeds (GB), University of Southern Denmark (DK), University of Oslo (NO), Aarhus University (DK), Norwegian University of Science and Technology (NO), Odense University Hospital (DK), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), Vejle Sygehus (DK), St Olav's University Hospital (NO)
Good health and well-being
Openalex Percentile: Top 3%
Lung Cancer Diagnosis and Treatment
7.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.